Article info

Download PDFPDF

Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Authors

  1. Correspondence to Dr Kamlesh Khunti; kk22{at}leicester.ac.uk
View Full Text

Citation

Pintat S, Fenici P, Hammar N, et al
Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Publication history

  • Received October 22, 2018
  • Revised January 8, 2019
  • Accepted January 16, 2019
  • First published March 21, 2019.
Online issue publication 
March 21, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.